Surface-modified nanoparticles for intracellular delivery of therapeutic agents and compositions for making same

a technology of surface modification and therapeutic agents, applied in the direction of nanocapsules, capsule delivery, microcapsules, etc., can solve the problems of limited understanding, lack of methodology for assessment of nanocapsules, and inability to achieve the development of efficient nanocapsules, so as to improve upon the efficiency of intracellular delivery of therapeutic agents and increase the force and occurrence of np interactions.

Inactive Publication Date: 2015-05-21
BOARD OF RGT UNIV OF NEBRASKA
View PDF2 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This patent text describes a method to modify polymeric nanoparticles to improve their interactions with cell membranes and enhance the delivery of therapeutic agents. The modified nanoparticles adhere to cell membranes with greater force and improve the efficiency of intracellular drug delivery, making them useful for cytoplasmic drug delivery.

Problems solved by technology

Though functionalization of NPs is increasingly explored, successful development of efficient nanocarriers is hindered by a limited understanding and lack of methodology for assessment of the nanocarrier interaction with cellular components as well as their intracellular trafficking.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Surface-modified nanoparticles for intracellular delivery of therapeutic agents and compositions for making same
  • Surface-modified nanoparticles for intracellular delivery of therapeutic agents and compositions for making same
  • Surface-modified nanoparticles for intracellular delivery of therapeutic agents and compositions for making same

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0029]PLGA-NPs with entrapped therapeutic agents are preferred for intracellular drug delivery owing to their biocompatibility, biodegradability and ability to sustain therapeutic drug levels for prolonged periods of time. The polymeric matrix prevents the degradation of the entrapped drug, and also allows precise control over the release kinetics of the drug from NPs. Polymeric NPs, formed from PLGA exhibit a negatively charged surface at neutral pH, owing to the presence of uncapped carboxylic acid end groups on the polymer. Based on the above-mentioned studies [6-8], it was hypothesized that the mechanism responsible for the observed rapid endo-lysosomal escape of polymeric NPs is selective surface charge reversal of NPs from anionic to cationic in the acidic pH of the endo-lysosomal compartment which facilitates the escape into the cytosolic compartment, thereby enhancing the efficiency of intracellular drug delivery (FIG. 1a). To test this hypothesis, surface modified NPs embod...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

Surface-modified polymeric nanoparticles (NPs), compositions for making them, and their use in drug delivery are disclosed.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS[0001]The present application is a continuation of U.S. patent application Ser. No. 12 / 184,715, filed Aug. 1, 2008, which claims the benefit of U.S. Provisional Patent Application No. 60 / 953,912, filed Aug. 3, 2007. The entire disclosure of each of the aforesaid applications is incorporated by reference in the present application.STATEMENT REGARDING FEDERAL SPONSORED RESEARCH OR DEVELOPMENT[0002]This invention was made with government support under Grant No. 1RO1 EB 003975-01A1 awarded by the U.S. National Institutes of Health. The Government has certain rights in this invention.BACKGROUND[0003]As a result of numerous studies elucidating the mechanism of targeted drug delivery, various drug-carrier systems (including nanoparticle (NP) systems), that incorporate a multi-functional surface are being developed. All such systems are based on the premise that particular ligands can only be recognized by specific cell-types and not by others, thus de...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K9/51
CPCA61K9/5153A61K9/5146A61K9/5138Y10S977/773Y10S977/906
Inventor LABHASETWAR, VINODVASIR, JASPREET
Owner BOARD OF RGT UNIV OF NEBRASKA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap